This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Salesforce.com (CRM) Up 16% Since Last Earnings Report?
by Zacks Equity Research
Salesforce.com (CRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Here's How Much a $1000 Investment in Salesforce.com Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Oracle's (ORCL) Healthcare Expansion to Aid Long-Term Growth
by Zacks Equity Research
Oracle's (ORCL) portfolio of healthcare offerings expands with the latest Oracle Health Insurance Data Exchange Cloud Service, which is expected to aid long-term growth.
Microsoft (MSFT) Faces Charges by EU for Bundling Teams, Office
by Zacks Equity Research
Microsoft (MSFT) violates European Union antitrust laws by bundling Teams with its other popular applications for businesses, per the EU, marking the bloc's latest challenge to a U.S. tech giant.
Oracle (ORCL) Launches AI Assistant for Healthcare Providers
by Zacks Equity Research
Oracle (ORCL) announces the general availability of its Clinical Digital Assistant, an AI-powered tool designed to improve patient care in ambulatory clinics across the United States.
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
The Zacks Analyst Blog Highlights Salesforce, Accenture, Equinix and Seneca Foods
by Zacks Equity Research
Salesforce, Accenture, Equinix and Seneca Foods are included in this Analyst Blog.
Top Research Reports for Salesforce, Accenture & Equinix
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Accenture plc (ACN) and Equinix, Inc. (EQIX), as well as a micro-cap stock Seneca Foods Corporation (SENEA).
NVIDIA ETFs Seesaw Last Week: What's in Store?
by Sanghamitra Saha
Chip behemoth NVIDIA (NVDA) just witnessed a volatile week, initially reaching all-time highs and then meeting with a reversal.
Here's Why Salesforce.com (CRM) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
EPAM Expands in Life Sciences Space With Odysseus Buyout
by Zacks Equity Research
EPAM acquires Odysseus Data Services to enhance its life sciences value chain by leveraging the latter's expertise in analytics, data methods and artificial intelligence.
Nice (NICE) Boosts Customer Experience With CXone Mpower
by Zacks Equity Research
Nice (NICE) transforms customer experience with CXone Mpower, enhancing its employee performance and delivering proactive services.
Company News for June 7, 2024
by Zacks Equity Research
Companies In The Article Are:CRM,LULU, FIVE,TTC.
Twilio (TWLO) Enhances Segment Capabilities With New Features
by Zacks Equity Research
Twilio (TWLO) enhances Segment's capabilities with Linked Audience and Twilio Data Graph features in an attempt to boost the platform's financial performance.
Does Oracle's (ORCL) Healthcare Roster Suggest Bright Prospects?
by Zacks Equity Research
Oracle's (ORCL) portfolio of offerings and increased adoption in the healthcare sector are expected to aid top-line growth in the near term.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investing in Salesforce.com (CRM)? Don't Miss Assessing Its International Revenue Trends
by Zacks Equity Research
Review Salesforce.com's (CRM) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Stock Market News for June 3, 2024
by Zacks Equity Research
U.S. stocks closed mixed on Friday as market participants digested a series of mixed economic data, which led to heightened speculation about interest rate cuts.
3 Reasons Why Growth Investors Shouldn't Overlook Salesforce.com (CRM)
by Zacks Equity Research
Salesforce.com (CRM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Salesforce.com (CRM) Upgraded to Buy: Here's Why
by Zacks Equity Research
Salesforce.com (CRM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why Salesforce.com (CRM) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Down -19.89% in 4 Weeks, Here's Why Salesforce.com (CRM) Looks Ripe for a Turnaround
by Zacks Equity Research
Salesforce.com (CRM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Stock Market News for May 31, 2024
by Zacks Equity Research
U.S. stock Markets closed sharply lower for second consecutive day following disappointing earnings results and guidance of a technology giant.